Effect of Comprehensive Geriatric Assessment on Short-time Mortality in Elderly Cancer Patients

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT03814213
Collaborator
Danish Cancer Society (Other)
781
2
3.3
390.5
120.1

Study Details

Study Description

Brief Summary

Older cancer patients referred to Oncology outpatient Clinic at Aarhus University Hospital have for a period been offered Comprehensive geriatric Assessment (CGA) as part of a routine practice. Oncology Department was responsible for planning the CGA. A number of patients did however not recieve this offer as planning failed. This Group of patients will be compared to patients recieving Geriatric assessment.

Patients recieving CGA is part of a Randomised controlled study (ID: NCT02837679) comparing CGA without 90 days follow-up to CGA with 90 days of Comprehensive geriatric care.

Patients are identified from electronic medical files. Data regarding death is obtained from Medical files.

Condition or Disease Intervention/Treatment Phase
  • Other: CGA
  • Other: tailored care

Detailed Description

Inclusion criteria:
  • 70 years or more

  • Cancer of the head and neck (HNC), lung (LC), upper gastro-intestinal- tract (UGI) or colo-rectal cancer (CRC)

  • Referred to the Outpatient Clinic at department of oncology at Aarhus University Hospital for cancer treatment.

  • Living in Aarhus, Favrskov, Odder or Skanderborg Municipalities

Exclusion:
  • Referred for specialised palliative care

Patients with both newly diagnosed cancer disease and patients with a relapse of previously treated cancer disease are included. Patients qualify for participation regardless of the stage of the cancer disease and regardless if specific cancer treatment is initiated.

The oncology department is responsible for identifying patients and informing of the planned CGA.

All potential patients referred to the oncology outpatient clinic are identified by retrospective review of lists of planned consultations in the oncology department out patient clinic available in the electronic medical file approximately once a week. By this procedure patients who were not informed of the possibility of having a CGA are identified (Group1) Patients who are referred for geriatric evaluation have a complete CGA at baseline. The CGA comprises 7 instruments for assessing health: Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) for autonomy, Mini Nutritional Status (MNA) for nutritional state, Mini Mental State Examination (MMSE) for Cognitive state, Geriatric Depression Scale 15-item (GDS) for mood and Cumulative Illness Rating Scale - Geriatrics (CIRS-G) for comorbidity and number of daily medication for polypharmacy as previously published. According to CGA, patients were given a CGA-status of "fit", "vulnerable" or "frail". In order to be "fit" all of the following should be present: Independence in ADL and IADL, less than 5 daily medications, no severe comorbidity and no more than 2 well controlled comorbidities, normal cognitive ability and no indications of depression or malnutrition. Information on whether or not the multidisciplinary team initiated any individual action/advice based on the CGA in group 1 and group 2 was registered as well. Interventions initiated by the multidisciplinary team were recorded in four categories: medical changes, nutritional intervention, physical intervention or social intervention. These interventions were registered before randomization was performed Frail and vulnerable patients are offered participation in a controlled randomized study (Clinical trialsID: NCT02837679). Patients are randomly and 1:1 assigned to either: No tailored follow-up (Group 2) or 90 days tailored follow up (group 3). Randomization were performed by REDcap and allocated equally by CGA-status (frail/vulnerable), gender and index tumor site (CRC or no-CRC).

It is not possible to blind patients or the multidisciplinary team of the randomization.

Group 2 has no tailored follow up on the problems found during CGA. Group 3 has 90 days tailored follow-up on problems that were identified during CGA and problems that evolved during the follow-up period.

Tailored follow-up The tailored intervention consists of phone calls, home visits, or contact to community care-takers. A multidisciplinary team consisting of a trained geriatric nurse and a geriatrician specialist performs the follow up. The team can perform clinical investigation of patients, initiate changes in medication, or referral to further investigation. Furthermore transfusion of blood, fluids or i.v. antibiotics could be performed either at home or in the geriatric out patient clinic.

Study Design

Study Type:
Observational
Actual Enrollment :
781 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Effect of Comprehensive Geriatric Assessment on Short-time Mortality in Elderly
Actual Study Start Date :
Jan 16, 2019
Actual Primary Completion Date :
Apr 1, 2019
Actual Study Completion Date :
Apr 25, 2019

Arms and Interventions

Arm Intervention/Treatment
No-CGA

Patients were not initially offered CGA due to no booking for CGA

CGA alone

Patients had CGA, but no tailored follow-up upon identified problems

Other: CGA
Multi-level Health assessment

CGA with tailored care

CGA and a tailored follow-up and care for 90 days following the CGA

Other: CGA
Multi-level Health assessment

Other: tailored care
Tailored care based on problems identified by CGA

Outcome Measures

Primary Outcome Measures

  1. short time mortality [90 days]

    dead within 90 days

Secondary Outcome Measures

  1. 1 year mortality [365 days]

    dead within 1 year

Eligibility Criteria

Criteria

Ages Eligible for Study:
70 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

cancer of head and neck, lung, upper or lower gastro intestinal Canal Referred for evaluation in oncology department out patient Clinic Living in Aarhus, Odder, Favrskov or Skanderborg municipality

-

Exclusion Criteria:

Referred for specialised palliative care

Contacts and Locations

Locations

Site City State Country Postal Code
1 Geriatric Department Aarhus University Hospital Aarhus Denmark 8000 C
2 Aarhus University Hospital Aarhus Denmark 8000

Sponsors and Collaborators

  • University of Aarhus
  • Danish Cancer Society

Investigators

  • Study Chair: Else M Damsgaard, DMsc, Aarhus University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marianne Ørum, Principal Investigator, University of Aarhus
ClinicalTrials.gov Identifier:
NCT03814213
Other Study ID Numbers:
  • 90-days mortality
First Posted:
Jan 23, 2019
Last Update Posted:
Apr 26, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marianne Ørum, Principal Investigator, University of Aarhus

Study Results

No Results Posted as of Apr 26, 2019